Results 241 to 250 of about 37,488 (288)

Why, how and in whom should we measure levels of lipoprotein(a): A review of the latest evidence and clinical implications

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Lipoprotein(a) [Lp(a)] is a genetically determined, causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve disease (CAVD). Despite robust evidence from epidemiological and genetic studies, Lp(a) remains underrecognised in clinical practice due to challenges in measurement, lack of guideline familiarity ...
Alexander C. Razavi   +4 more
wiley   +1 more source

Per- and polyfluoroalkyl substances, apolipoproteins and the risk of coronary heart disease in US men and women. [PDF]

open access: yesEnviron Health
Zhu L   +7 more
europepmc   +1 more source

New approach to specific Alzheimer's disease diagnosis based on plasma biomarkers in a cognitive disorder cohort

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
Abstract Background The validation of a combination of plasma biomarkers and demographic variables is required to establish reliable cut‐offs for Alzheimer's disease diagnosis (AD). Methods Plasma biomarkers (Aβ42/Aβ40, p‐Tau181, t‐Tau, NfL, GFAP), ApoE genotype, and demographic variables were obtained from a retrospective clinical cohort of cognitive ...
Lourdes Álvarez‐Sánchez   +8 more
wiley   +1 more source

Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
This consensus highlights critical research gaps in obesity epidemiology, phenotypic heterogeneity and clinical management, calling for advanced methodologies, collaborative strategies and innovative policies to mitigate the global obesity epidemic and its socio‐economic impacts.
Federico Carbone   +28 more
wiley   +1 more source

Uncovering host response in adults with severe community-acquired pneumonia: a proteomics and metabolomics perspective study. [PDF]

open access: yesWorld J Emerg Med
Kuang Z   +10 more
europepmc   +1 more source

Cardioprotective effects of the extracellular chaperone clusterin in acute myocardial infarction

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
In vivo, CLU−/− mice were more susceptible to acute myocardial infarction than CLU+/+ mice. Moreover, inflammation and histone levels were significantly increased in CLU−/− mice compared to CLU+/+ mice following ischemia/reperfusion. In vitro, CLU protects cardiomyocytes from histone‐ and/or hypoxia‐induced cell death.
Louwana Allawa   +12 more
wiley   +1 more source

Concordance‐discordance between apolipoprotein B and lipid biomarkers in predicting 20‐year atherosclerotic cardiovascular disease risk: The ATTICA study (2002–2022)

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
This study examined the association between 20‐year atherosclerotic cardiovascular disease (ASCVD) risk and discordance among apolipoprotein B100 (apoB) and lipid biomarkers, using established thresholds. ApoB strongly correlated with LDL‐C and non‐HDL‐C, though concordance was limited.
Sofia‐Panagiota Giannakopoulou   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy